Moolec Science (MLEC) Research & Development (2022 - 2024)
Moolec Science (MLEC) reported Research & Development of -$298003.0 for Q4 2024, up 42.25% on a YoY basis from -$209492.5 in Q1 2024, and up 29.97% sequentially from -$425542.0 in Q3 2024.
Moolec Science (MLEC) Research & Development (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Research & Development data on file, last reported at -$298003.0 in Q4 2024.
- For the quarter ending Q4 2024, Research & Development rose 42.25% year-over-year to -$298003.0; the trailing twelve-month figure through Dec 2024 stood at -$1.6 million (up 13.97% YoY), and the FY2024 full-year result was -$1.8 million, down 31.16% from the prior year.
- Research & Development improved to -$298003.0 in Q4 2024, from -$425542.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $176161.0 in Q1 2022 to a low of -$1.7 million in Q2 2022.
- A 3-year average of -$447020.3 and a median of -$404315.5 in 2023 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 78.11% in 2023, while the deepest fall reached 1535.21% in 2023.
- Tracing MLEC's Research & Development over 3 years: stood at -$31557.0 in 2022, then plunged by 1535.21% to -$516022.0 in 2023, then jumped by 42.25% to -$298003.0 in 2024.
- Business Quant data shows MLEC's Research & Development at -$298003.0 in Q4 2024, -$425542.0 in Q3 2024, and -$420895.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -298,003.00 |
| Sep 30, 2024 | -425,542.00 |
| Jun 30, 2024 | -420,895.00 |
| Mar 31, 2024 | -447,621.00 |
| Dec 31, 2023 | -516,022.00 |
| Sep 30, 2023 | -387,736.00 |
| Jun 30, 2023 | -370,632.00 |
| Mar 31, 2023 | -576,096.00 |
| Dec 31, 2022 | -31,557.00 |
| Sep 30, 2022 | -372,932.00 |
| Jun 30, 2022 | -1.69 Mn |
| Mar 31, 2022 | 176,161.00 |